Please provide your email address to receive an email when new articles are posted on . An ongoing study showed improvements in SSc severity, disease-related pain, Raynaud’s symptoms and ...
New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these ...
If you have hypertrophic cardiomyopathy (HCM) and are experiencing symptoms such as shortness of breath, chest pain, ...
Active ingredient: Clevidipine butyrate emulsion 0.5 mg/mL; solution for IV infusion; contains lipids 0.2 g/mL (soybean oil, egg phospholipids). Indication: To reduce BP when oral therapy is not ...
Praxis Precision Medicines' ulixacaltamide (PRAX-944) is a potent and selective small molecule T-type Ca2+ channel blocker being developed for the potential treatment of essential tremor. ET is a ...
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment. The ...
A systematic review evaluated the efficacy of calcium channel blockers or alpha blockers for the treatment of urinary stones in nine randomized trials with 693 patients (Lancet. 2006;368:1171-1179).
I have found that some patients with depression seem to improve when calcium blockers are discontinued. Are there any data to support this? What would be your preference as a replacement for a calcium ...
A new retrospective analysis of data from over 400,000 UK Biobank participants has revealed that calcium channel blockers (CCBs), but not other antihypertensive agents, were associated with an ...
NEW YORK (Reuters Health) - Older adults on blood pressure drugs known as calcium channel blockers could suffer dangerous drops in blood pressure if they are given certain antibiotics, according to a ...
Please provide your email address to receive an email when new articles are posted on . CCB users had 39% higher odds of glaucoma on average, as well as thinner inner retinal thickness, vs. non-users.